#Ralinepag

Explore our comprehensive coverage of ralinepag, including scientific research, policy developments, environmental impacts, and solutions for a sustainable future.

1Articles

1Authors

5Total Views

Phase 3 ADVANCE OUTCOMES Trial: Oral Ralinepag Reduces Clinical Worsening in Pulmonary Arterial Hypertension by 55%

Featured

By Olivia Grace ChenAug 08, 2026

Phase 3 ADVANCE OUTCOMES Trial: Oral Ralinepag Reduces Clinical Worsening in Pulmonary Arterial Hypertension by 55%

A phase 3 randomized trial published in The Lancet on August 8, 2026, reveals that the oral drug ralinepag reduces the risk of clinical worsening in p...

Read Full Story →

#Ralinepag

Phase 3 ADVANCE OUTCOMES Trial: Oral Ralinepag Reduces Clinical Worsening in Pulmonary Arterial Hypertension by 55%

Recent Articles